ExamWorks Group (NYSE: EXAM ) is expected to report Q2 earnings on Aug. 2. Here's what Wall Street wants to see.
The 10-second takeaway
Comparing the upcoming quarter with the prior-year quarter, average analyst estimates predict ExamWorks Group's revenues will improve 17.2% and EPS will grow NA.
The average estimate for revenue is $125.1 million. On the bottom line, the average EPS estimate is -$0.11.
Last quarter, ExamWorks Group notched revenue of $123.7 million. GAAP reported sales were 86% higher than the prior-year quarter's $66.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.13. GAAP EPS were -$0.13 for Q1 versus -$0.02 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 34.4%, 20 basis points worse than the prior-year quarter. Operating margin was 0.0%, 130 basis points worse than the prior-year quarter. Net margin was -3.5%, 270 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $521.7 million. The average EPS estimate is -$0.37.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 13 members out of 21 rating the stock outperform, and eight members rating it underperform. Among eight CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give ExamWorks Group a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ExamWorks Group is outperform, with an average price target of $12.75.
The healthcare investing landscape is littered with also-rans and a few major winners. Is ExamWorks Group prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Get instant access to this free report.